Estrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavonoids

被引:159
作者
Le Bail, JC
Varnat, F
Nicolas, JC
Habrioux, G
机构
[1] Fac Pharm, Biochim Lab, UPRES EA 1085, F-87025 Limoges, France
[2] INSERM, U439, F-34090 Montpellier, France
关键词
MCF-7; cells; estrogen receptor; flavonoids; luciferase activity;
D O I
10.1016/S0304-3835(98)00141-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The interaction between the estrogen receptor and a variety of flavonoids was studied in the presence or absence of estradiol using a stably-transfected human boast cancer cell line (MVLN). On the other hand, flavonoids were evaluated for their effects on proliferation in estrogen-dependent (MCF-7) and independent (MDA-MB231) human breast cancer cells. We established a relationship structure-activity and determined regions and/or substituents essential for estrogenic or antiestrogenic activities. In contrast, we did not find the same relationship for cell proliferation. Among all flavonoids used, only 7-methoxyflavanone and 7,8-dihydroxyflavone at high concentrations (50 mu M) possess antiestrogenic and antiproliferative activities. These results suggest that two hydroxyls (in positions 7 and 8) or 7-methoxy substituents are essential for the antiestrogenic activity of flavonoids. However, it seems that flavonoids at high concentrations exert their antiproliferative activity through other estrogen receptor-independent mechanisms. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:209 / 216
页数:8
相关论文
共 26 条
[21]  
PONS M, 1990, BIOTECHNIQUES, V9, P450
[22]   NARINGENIN - A WEAKLY ESTROGENIC BIOFLAVONOID THAT EXHIBITS ANTIESTROGENIC ACTIVITY [J].
RUH, MF ;
ZACHAREWSKI, T ;
CONNOR, K ;
HOWELL, J ;
CHEN, I ;
SAFE, S .
BIOCHEMICAL PHARMACOLOGY, 1995, 50 (09) :1485-1493
[23]  
SO VF, 1996, NUTR CANC, V26, P167
[24]   ANTIVIRAL ACTIVITY OF FLAVONES AND POTENTIATION BY ASCORBATE [J].
VRIJSEN, R ;
EVERAERT, L ;
BOEYE, A .
JOURNAL OF GENERAL VIROLOGY, 1988, 69 :1749-1751
[25]   Molecular effects of genistein on estrogen receptor mediated pathways [J].
Wang, TTY ;
Sathyamoorthy, N ;
Phang, JM .
CARCINOGENESIS, 1996, 17 (02) :271-275
[26]  
YANAGIHARA K, 1993, CANCER RES, V53, P5815